Mitogen-activated protein kinase 14 (MAPK14, aka p38) contributes to aggressive disease in hepatocellular carcinoma, gastric cancer, and renal cell carcinoma [37,38,39]. This evidence concerns the gene MAPK14 and renal cell carcinoma.